![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, September 20, 2023 8:36:40 AM
Recent BJDX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:45:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/16/2024 08:13:11 PM
- Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering • GlobeNewswire Inc. • 06/28/2024 03:32:47 PM
- Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering • GlobeNewswire Inc. • 06/27/2024 12:58:01 PM
- SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients • GlobeNewswire Inc. • 06/26/2024 12:00:00 PM
- Bluejay Diagnostics Announces Reverse Stock Split • GlobeNewswire Inc. • 06/17/2024 12:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/17/2024 11:10:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 09:24:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 01:25:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:58:54 PM
- Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering • GlobeNewswire Inc. • 01/02/2024 10:58:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 10:21:42 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 12/29/2023 10:06:56 PM
- Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering • GlobeNewswire Inc. • 12/28/2023 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/28/2023 05:15:12 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/27/2023 07:29:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 02:14:38 PM
- Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) • GlobeNewswire Inc. • 12/27/2023 02:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/21/2023 10:20:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:17:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:16:33 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/21/2023 10:27:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:05:30 PM
- Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/09/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:01:27 PM
FEATURED POET Technologies Reports Second Quarter 2024 Financial Results • Aug 15, 2024 8:04 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
ATWEC Reaches Profitability, Announces Massive Earnings Growth, and a Strong Forecast for the Rest of 2024 • ATWT • Aug 15, 2024 7:16 AM